| Primary |
| Product Used For Unknown Indication |
57.1% |
| Prophylaxis |
28.6% |
| Peripheral Arterial Occlusive Disease |
14.3% |
|
| Iron Deficiency Anaemia |
100.0% |
|
| Secondary |
| Bipolar I Disorder |
20.5% |
| Ischaemic Cardiomyopathy |
20.5% |
| Parkinson's Disease |
15.4% |
| Product Used For Unknown Indication |
10.3% |
| Thrombosis Prophylaxis |
10.3% |
| Cardiac Failure |
7.7% |
| Arrhythmia |
5.1% |
| Thyroid Disorder |
5.1% |
| Arthralgia |
2.6% |
| Prostate Cancer |
2.6% |
|
| Psychotic Disorder |
16.7% |
| Anaemia |
8.3% |
| Conjunctival Haemorrhage |
8.3% |
| Drug Interaction |
8.3% |
| Gastric Ulcer Haemorrhage |
8.3% |
| Haematoma |
8.3% |
| Haemorrhagic Erosive Gastritis |
8.3% |
| Ocular Hyperaemia |
8.3% |
| Pallor |
8.3% |
| Purpura |
8.3% |
| Skin Lesion |
8.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.0% |
| Drug Use For Unknown Indication |
15.5% |
| Hypertension |
11.3% |
| Diabetes Mellitus |
8.6% |
| Myocardial Ischaemia |
5.4% |
| Type 2 Diabetes Mellitus |
3.6% |
| Atrial Fibrillation |
2.3% |
| Cardiac Failure |
2.3% |
| Depression |
2.3% |
| Hypertensive Heart Disease |
2.3% |
| Prophylaxis |
2.3% |
| Myocardial Infarction |
2.0% |
| Benign Prostatic Hyperplasia |
1.8% |
| Bronchitis |
1.6% |
| Hypercholesterolaemia |
1.6% |
| Parkinson's Disease |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
| Cardiomyopathy |
1.4% |
| Pain |
1.4% |
|
| Syncope |
11.4% |
| Renal Failure Acute |
10.2% |
| Vertigo |
10.2% |
| Hyponatraemia |
8.0% |
| Rhabdomyolysis |
6.8% |
| Vomiting |
6.8% |
| Gastrointestinal Haemorrhage |
4.5% |
| Presyncope |
4.5% |
| Sopor |
4.5% |
| Urinary Retention |
4.5% |
| Urticaria |
4.5% |
| Paraesthesia |
3.4% |
| Rash |
3.4% |
| Tremor |
3.4% |
| Cutaneous Lupus Erythematosus |
2.3% |
| Dementia |
2.3% |
| Hyperkalaemia |
2.3% |
| Hypoglycaemia |
2.3% |
| Hypotension |
2.3% |
| Loss Of Consciousness |
2.3% |
|
| Interacting |
| Product Used For Unknown Indication |
57.1% |
| Acute Myocardial Infarction |
21.4% |
| Chronic Obstructive Pulmonary Disease |
7.1% |
| Pain In Extremity |
7.1% |
| Prophylaxis |
7.1% |
|
| Renal Failure Acute |
50.0% |
| Drug Interaction |
25.0% |
| Melaena |
25.0% |
|
